Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jennifer H. Foster"'
Autor:
Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno-Smith, Tajhal D. Patel, Barry Zorman, Andrew Badachhape, Blanca E. Hernandez, Amber B. Wolf, Zihua Zeng, Jennifer H. Foster, Sara Aloisi, Pavel Sumazin, Youli Zu, John Hicks, Ketan B. Ghaghada, Nagireddy Putluri, Giovanni Perini, Cristian Coarfa, Eveline Barbieri
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Half of high-risk neuroblastoma patients have MYCN amplification. Here, the authors show that MYCN induces fatty acid uptake and synthesis to support neuroblastoma and inhibition of a fatty acid transporter impairs tumor progression in preclinical mo
Externí odkaz:
https://doaj.org/article/f46634316a174b53a1daa084ab8c5d23
Autor:
Julie Krystal, Jennifer H. Foster
Publikováno v:
Children, Vol 10, Iss 8, p 1302 (2023)
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the cu
Externí odkaz:
https://doaj.org/article/7fdf472319b34972be7887ad4d20506a
Autor:
Lauren T. Callaghan, Anthea Lafreniere, Ekene A. Onwuka, Ross M. Beckman, Jennifer H. Foster, Norma Quintanilla, Charleta Guillory, Timothy C. Lee, Lily S. Cheng
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Spontaneous intestinal perforations in the neonatal population are mostly associated with low birth weight, prematurity, and necrotizing enterocolitis. Spontaneous intestinal perforation in the absence of these risk factors is extremely rare and shou
Externí odkaz:
https://doaj.org/article/d89a6a1e706845639df224cd05f181f3
Autor:
Benjamin J. Lerman, Yimei Li, Cecilia Carlowicz, Meaghan Granger, Thomas Cash, Arhanti Sadanand, Katherine Somers, Aeesha Ranavaya, Brian D. Weiss, Michelle Choe, Jennifer H. Foster, Navin Pinto, Daniel A. Morgenstern, Margarida Simão Rafael, Keri A. Streby, Rachel N. Zeno, Rajen Mody, Sahr Yazdani, Ami V. Desai, Margaret E. Macy, Suzanne Shusterman, Sara M. Federico, Rochelle Bagatell
Publikováno v:
Journal of Clinical Oncology. 41:508-516
PURPOSE Although chemoimmunotherapy is widely used for treatment of children with relapsed high-risk neuroblastoma (HRNB), little is known about timing, duration, and evolution of response after irinotecan/temozolomide/dinutuximab/granulocyte-macroph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::087d73cbd614f1c5b34eeec3c35e0536
https://doi.org/10.1200/jco.22.01273
https://doi.org/10.1200/jco.22.01273
Autor:
Ami V. Desai, Mark A. Applebaum, Theodore G. Karrison, Akosua Oppong, Cindy Yuan, Katherine R. Berg, Kyle MacQuarrie, Elizabeth Sokol, Anurekha G. Hall, Navin Pinto, Ian Wolfe, Rajen Mody, Suzanne Shusterman, Valeria Smith, Jennifer H. Foster, Michele Nassin, James L. LaBelle, Rochelle Bagatell, Susan L. Cohn
Publikováno v:
Cancer. 128:2967-2977
High-risk neuroblastoma patients with end-induction residual disease commonly receive post-induction therapy in an effort to increase survival by improving the response before autologous stem cell transplantation (ASCT). The authors conducted a multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::990ab842f74eb4a1ccfb5cd80eca1ab0
https://doi.org/10.1002/cncr.34263
https://doi.org/10.1002/cncr.34263
Autor:
Yael P. Mossé, Brenda J. Weigel, Susan M. Blaney, Peter C. Adamson, Elizabeth Fox, Stacey L. Berg, Keith Wilner, Frank M. Balis, Charles G. Minard, David C. Hall, Stephan D. Voss, Jennifer H. Foster
Purpose:Anaplastic lymphoma kinase (ALK) aberrations are a promising target for patients with neuroblastoma. We assessed the activity of first-generation ALK inhibitor crizotinib in patients with no known curative treatments and whose tumors harbored
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846be02661708377f2281440378d489e
https://doi.org/10.1158/1078-0432.c.6530406
https://doi.org/10.1158/1078-0432.c.6530406
Autor:
Yael P. Mossé, Brenda J. Weigel, Susan M. Blaney, Peter C. Adamson, Elizabeth Fox, Stacey L. Berg, Keith Wilner, Frank M. Balis, Charles G. Minard, David C. Hall, Stephan D. Voss, Jennifer H. Foster
Supp Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0068f82fad02830ba3b8acdd49953b
https://doi.org/10.1158/1078-0432.22480263.v1
https://doi.org/10.1158/1078-0432.22480263.v1
Autor:
Ami V Desai, Giles W Robinson, Karen Gauvain, Ellen M Basu, Margaret E Macy, Luke Maese, Nicholas S Whipple, Amit J Sabnis, Jennifer H Foster, Suzanne Shusterman, Janet Yoon, Brian D Weiss, Mohamed S Abdelbaki, Amy E Armstrong, Thomas Cash, Christine A Pratilas, Nadège Corradini, Lynley V Marshall, Mufiza Farid-Kapadia, Saibah Chohan, Clare Devlin, Georgina Meneses-Lorente, Alison Cardenas, Katherine E Hutchinson, Guillaume Bergthold, Hubert Caron, Edna Chow Maneval, Amar Gajjar, Elizabeth Fox
Publikováno v:
Neuro-Oncology. 24:1776-1789
Background Entrectinib is a TRKA/B/C, ROS1, ALK tyrosine kinase inhibitor approved for the treatment of adults and children aged ≥12 years with NTRK fusion-positive solid tumors and adults with ROS1 fusion-positive non–small-cell lung cancer. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03639f7f0384b3824fab7613aeb1e8fa
https://doi.org/10.1093/neuonc/noac087
https://doi.org/10.1093/neuonc/noac087
Autor:
Neil Chevli, David R. Grosshans, Mary Frances McAleer, Jennifer H Foster, Douglas Harrison, Susan L. McGovern, Arnold C. Paulino
Publikováno v:
Pediatric bloodcancerREFERENCES. 70(1)
The purpose of this study is to analyze renal function outcomes in abdominal neuroblastoma patients undergoing proton therapy (PT).From 2011 to 2019, two single-institution Institutional Review Board-approved protocols prospectively enrolled neurobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9279e5060040b57d6e0f26402016c10f
https://pubmed.ncbi.nlm.nih.gov/36129239
https://pubmed.ncbi.nlm.nih.gov/36129239
Autor:
Justin A. Kahla, David A. Siegel, Shifan Dai, Philip J. Lupo, Jennifer H. Foster, Michael E. Scheurer, Andras A. Heczey
Publikováno v:
Pediatric Blood & Cancer. 69
Hepatoblastoma (HB) is the most common pediatric primary malignant liver tumor, its incidence has been increasing worldwide, but recent changes in incidence and outcomes with high population coverage are not well characterized.We defined the incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a552b1f599bcb1d2a450fd5ca45d2a
https://doi.org/10.1002/pbc.29763
https://doi.org/10.1002/pbc.29763